Evidence map›Paper›PMID 29809138›Full record

ArticleeLife2018

Microglial transglutaminase-2 drives myelination and myelin repair via GPR56/ADGRG1 in oligodendrocyte precursor cells.

Stefanie Giera, Rong Luo, Yanqin Ying, Sarah D Ackerman, Sung-Jin Jeong, Hannah M Stoveken, Christopher J Folts, Christina A Welsh, Gregory G Tall, Beth Stevens and 2 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 88 papers.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 135 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Adhesion G protein-coupled receptors.Pharmacological reviews · 2026
    Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. The far extracellular CUB domain of the adhesion GPCR ADGRG6/GPR126 is a key regulator of receptor signaling.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Stefanie GieraDivision of Newborn Medicine, Department of Medicine, Children's Hospital and Harvard Medical School, Boston, United States.ORCID http://orcid.org/0000-0002-7414-0562
Rong LuoDivision of Newborn Medicine, Department of Medicine, Children's Hospital and Harvard Medical School, Boston, United States.
Yanqin YingDivision of Newborn Medicine, Department of Medicine, Children's Hospital and Harvard Medical School, Boston, United States.
Sarah D AckermanDepartment of Developmental Biology, Washington University School of Medicine, St. Louis, United States.ORCID http://orcid.org/0000-0001-8752-8972
Sung-Jin JeongDivision of Newborn Medicine, Department of Medicine, Children's Hospital and Harvard Medical School, Boston, United States.
Hannah M StovekenDepartment of Pharmacology, University of Michigan Medical Center, Ann Arbor, United States.
Christopher J FoltsDivision of Newborn Medicine, Department of Medicine, Children's Hospital and Harvard Medical School, Boston, United States.ORCID http://orcid.org/0000-0002-0448-3711
Christina A WelshDepartment of Neurology, F. M. Kirby Neurobiology Center, Children's Hospital and Harvard Medical School, Boston, United States.ORCID https://orcid.org/0000-0001-9802-725X
Gregory G TallDepartment of Pharmacology, University of Michigan Medical Center, Ann Arbor, United States.
Beth StevensDepartment of Neurology, F. M. Kirby Neurobiology Center, Children's Hospital and Harvard Medical School, Boston, United States.ORCID http://orcid.org/0000-0003-4226-1201
Kelly R MonkDepartment of Developmental Biology, Washington University School of Medicine, St. Louis, United States.
Xianhua PiaoDivision of Newborn Medicine, Department of Medicine, Children's Hospital and Harvard Medical School, Boston, United States.ORCID http://orcid.org/0000-0001-7540-6767
Boston Children's Hospital · USUniversity of Michigan · USOregon Health & Science University · USUniversity of Oregon · US

Funding

Mouse Neurodevelopmental Behavior CoreU54HD090255 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI POMEROY, SCOTT LOREN · 2016 to 2020
$5.2M
Adhesion G Protein-Coupled Receptors in CNS Development and RegenerationR01NS094164 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PIAO, XIANHUA · 2015 to 2025
$4.5M
MOLECULAR AND GENETIC ANALYSIS OF GPR126 IN PERIPHERAL NERVE.R01NS079445 · NINDS · WASHINGTON UNIVERSITY · PI MONK, KELLY R · 2012 to 2020
$3.1M
Mechanisms of Adhesion GPCR ActionR01GM120110 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TALL, GREGORY GORDON · 2016 to 2023
$2.4M
Role of Adhesion G protein-coupled receptors in glial cell development and myelinationR56NS085201 · NINDS · BOSTON CHILDREN'S HOSPITAL · PI PIAO, XIANHUA · 2015 to 2015
$447k
Gpr56 is a regulator of glial cell development and myelinationF31NS087801 · NINDS · WASHINGTON UNIVERSITY · PI ACKERMAN, SARAH D · 2014 to 2016
$68k
NICHD NIH HHS U54 HD090255NIGMS NIH HHS R01 GM120110NINDS NIH HHS F31 NS087801NINDS NIH HHS NS079445NINDS NIH HHS NS08520NINDS NIH HHS NS085201NINDS NIH HHS NS085201 (R56)NINDS NIH HHS NS087801NINDS NIH HHS NS094164NINDS NIH HHS R01 NS079445NINDS NIH HHS R01 NS094164NINDS NIH HHS R56 NS085201
6 · The paper itself

Abstract

In the central nervous system (CNS), myelin formation and repair are regulated by oligodendrocyte (OL) lineage cells, which sense and integrate signals from their environment, including from other glial cells and the extracellular matrix (ECM). The signaling pathways that coordinate this complex communication, however, remain poorly understood. The adhesion G protein-coupled receptor ADGRG1 (also known as GPR56) is an evolutionarily conserved regulator of OL development in humans, mice, and zebrafish, although its activating ligand for OL lineage cells is unknown. Here, we report that microglia-derived transglutaminase-2 (TG2) signals to ADGRG1 on OL precursor cells (OPCs) in the presence of the ECM protein laminin and that TG2/laminin-dependent activation of ADGRG1 promotes OPC proliferation. Signaling by TG2/laminin to ADGRG1 on OPCs additionally improves remyelination in two murine models of demyelination. These findings identify a novel glia-to-glia signaling pathway that promotes myelin formation and repair, and suggest new strategies to enhance remyelination.

Indexed as

AnimalsCell DifferentiationCell LineageCerebellumCX3C Chemokine Receptor 1Demyelinating DiseasesFemaleGene Expression Regulation, DevelopmentalGTP-Binding ProteinsHumansLamininMaleMiceMice, KnockoutMicrogliaNeurogenesisAdgrg1 protein, mouseCX3C Chemokine Receptor 1Cx3cr1 protein, mouseGTP-Binding ProteinsLamininProtein Glutamine gamma Glutamyltransferase 2Receptor, Platelet-Derived Growth Factor alphaReceptors, G-Protein-CoupledTransglutaminasesmicrogliamousemyelinationneuroscienceoligodendrocyteremyelinationzebrafish

Identifiers

PMID29809138
PMCPMC5980231
OpenAlexW2805257681

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.